Clinical Trial Update: Safety of Administering Isoniazid to SLE Patients to Prevent TB [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update evaluating the safety of administering isoniazid to patients with systemic lupus erythematosus to prevent tuberculosis, covering Phase 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus
• Tuberculosis

Drugs mentioned

• ISONIAZID (ISONIAZID)

Snippet

Sponsor: Universitas Padjadjaran | Conditions: Tuberculosis, Systemic Lupus Erythematosus | Phase 2, Phase 3 | Status: RECRUITING